Literature DB >> 19239362

Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India.

Mohanarani Suhadev1, Adeline M Nyamathi, Soumya Swaminathan, Anitha Suresh, P Venkatesan.   

Abstract

Abstract Successful conduct of any HIV vaccine trial (HIVVT) requires a high level of preparedness in the community. A cross-sectional study was conducted in Tamilnadu, India among 501 participants from six different risk groups to investigate their willingness to participate (WTP) in future preventive HIVVTs and to explore their knowledge and attitude toward preventive HIV vaccines. In total, 82% were willing to participate and the desire to be protected from HIV was the main reason for WTP. Perception of not being at risk was the major reason for refusal among married women. The knowledge scale showed a significant increase in scores after vaccine education. In all, 76% revealed the hope that there would be an effective vaccine in a few years and 71% hoped that the HIV vaccine would protect them from HIV infection. The main concern was the unknown efficacy of the vaccine (50%) and the effects of an HIV vaccine on participants' lives (51%). Overall, 76% agreed that sex without a condom would not be safe whether or not there was an HIV vaccine. To conclude, it is likely that high-risk volunteers will be willing to enroll in preventive HIVVTs. Addressing barriers and concerns by providing information through appropriate agencies will spell out success for preventive HIVVTs in India.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239362     DOI: 10.1089/aid.2007.0312

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  16 in total

1.  Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Joachim Mwami; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  BMC Public Health       Date:  2010-05-28       Impact factor: 3.295

2.  Depression, social support, and stigma as predictors of quality of life over time: results from an Asha-based HIV/AIDS intervention in India.

Authors:  Dana Rose Garfin; Sanghyuk S Shin; Maria L Ekstrand; Kartik Yadav; Catherine L Carpenter; Sanjeev Sinha; Adeline M Nyamathi
Journal:  AIDS Care       Date:  2019-02-03

3.  Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.

Authors:  Barbara S Mensch; Barbara A Friedland; Sharon A Abbott; Lauren L Katzen; Waimar Tun; Christine A Kelly; Avina Sarna; Aylur K Srikrishnan; Suniti Solomon
Journal:  AIDS Behav       Date:  2013-02

4.  High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.

Authors:  Noah Kiwanuka; Ali Ssetaala; Juliet Mpendo; Matthias Wambuzi; Annet Nanvubya; Simon Sigirenda; Annet Nalutaaya; Paul Kato; Leslie Nielsen; Pontiano Kaleebu; Josephine Nalusiba; Nelson K Sewankambo
Journal:  J Int AIDS Soc       Date:  2013-07-22       Impact factor: 5.396

5.  Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.

Authors:  M Florencia Etcheverry; Jennifer L Evans; Emilia Sanchez; Eva Mendez-Arancibia; Mercé Meroño; José M Gatell; Kimberly Page; Joan Joseph
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

6.  Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.

Authors:  E A M Tarimo; M Bakari; D C V Kakoko; T W Kohi; F Mhalu; E Sandstrom; A Kulane
Journal:  BMC Public Health       Date:  2016-02-24       Impact factor: 3.295

7.  Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.

Authors:  Gershim Asiki; Andrew Abaasa; Eugene Ruzagira; Freddie Kibengo; Ubaldo Bahemuka; Jerry Mulondo; Janet Seeley; Linda-Gail Bekker; Sinead Delany; Pontiano Kaleebu; Anatoli Kamali
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

8.  Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.

Authors:  Venkatesan Chakrapani; Peter A Newman; Neeti Singhal; Jhalak Jerajani; Murali Shunmugam
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

9.  'What do I know? Should I participate?' Considerations on participation in HIV related research among HIV infected adults in Bangalore, South India.

Authors:  Rashmi J Rodrigues; Jimmy Antony; Shubha Krishnamurthy; Anita Shet; Ayesha De Costa
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

10.  Factors that influence the willingness of young adults in Dar es Salaam, Tanzania, to participate in phase I/II HIV vaccine trials.

Authors:  Theodora Mbunda; Muhammad Bakari; Edith A M Tarimo; Eric Sandstrom; Asli Kulane
Journal:  Glob Health Action       Date:  2014-02-25       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.